The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathologic complete response (pCR) to neoadjuvant treatment (NAT) with carboplatin, nab-paclitaxel and anthracycline in early and locally advanced triple-negative breast cancer (TNBC).
 
Isabel Miras
Travel, Accommodations, Expenses - MSD/AstraZeneca
 
Ana Gil
Speakers' Bureau - Daiichi Sankyo Pharmaceutical
Travel, Accommodations, Expenses - Roche
 
Paloma Santos-Fernandez
Speakers' Bureau - Advanz Pharma; Leo Pharma; SERVIER
 
Alberto Sánchez-Camacho
No Relationships to Disclose
 
Alejandro Falcon Gonzalez
Consulting or Advisory Role - Medtronic; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo Pharmaceutical
 
Marta Benavent
Consulting or Advisory Role - Ipsen; Novartis; Pfizer
Speakers' Bureau - Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Mónica Cejuela Solís
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo Pharmaceutical; Novartis; Pfizer
 
Salvador Bofill
Honoraria - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Pfizer
Consulting or Advisory Role - Daiichi Sankyo Pharmaceutical; Lilly O.
Research Funding - AstraZeneca; Lilly O.; Novartis; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Sandra Flores
No Relationships to Disclose
 
Manuel Ruiz-Borrego
No Relationships to Disclose